-
Research Imaging Core Center
Core facilities offer advice on technical feasibility, experimental design and data analysis to optimize cost and outcome.
-
Amsterdam UMC
-
Research
-
Core facilities
-
Winning combination of drugs for treating Chronic Lymphocytic Leukemia
Patients with Chronic Lymphocytic Leukemia (CLL) are better off with a combination of ibrutinib and venetoclax. This is more effective than the standard treatment, researchers of Amsterdam UMC discovered.
-
Mission and vision diversity and inclusion Amsterdam UMC
If there is one organisation that can draw on differences, it is Amsterdam UMC with its very diverse patient groups and 17,000 colleagues. Read more about our mission and vision.
-
About Amsterdam UMC
-
Working at
-
Diversity
-
-
-
About the Spinoza Chair
About...
-
'Data of ICU patients can answer thousands of questions'
ICUdata is an ambitious data-sharing project. Intensivist Paul Elbers, one of the initiators, is enthusiastic about the project that is entering its next phase – and it’s going far beyond its initial scope.
-
Prescribing of medication did not always go smoothly during corona pandemic
The first patients to visit Amsterdam UMC's "post-covid-19 outpatient clinic" in 2020 taught doctors and pharmacists an important lesson: in times of a crisis, information about medication can easily be jeopardized. "This is a valuable lesson for the crises that are doubtless still to come."
-
New drug to treat rare swelling disorder
Patients with hereditary angioedema often experience sudden swelling in their body that can be extremely painful, disabling and sometimes even fatal. A new drug can prevent these attacks and greatly improve their quality of life, according to an international study coordinated by Amsterdam UMC.
-
Writing and presenting in Amsterdam UMC
Read more about writing and presenting in Amsterdam UMC.
-
About Amsterdam UMC
-
News and media
-
Press
